Leerink Partners is a venture debt provider. Team members are concentrated in Boston, Massachusetts, United States. Among the 11 companies in the known portfolio are Parabilis Medicines, Odyssey Therapeutics, Precision BioSciences, Kalaris Therapeutics, Avrobio and Zura Bio.
Is Leerink Partners a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Who to pitch at Leerink Partners
Leerink Partners portfolio companies (11)
- Parabilis Medicines
- Odyssey Therapeutics
- Precision BioSciences
- Kalaris Therapeutics
- Avrobio
- Zura Bio
- Arcus Biosciences
- Replimune Group
- Fulcrum Therapeutics
- Generation Bio
- Kinnate Biopharma
Co-investors
Funds that share portfolio companies with Leerink Partners.
Similar funds
Showing 20 of 100
About Leerink Partners
The firm's listing covers sector Healthcare, and focus areas Biotech, Drug Discovery, Genomics and Pharma; known deals cluster at Growth and Series B.
The team counts 4 people in our database. Jeffrey Leerink (Chairman and CEO Leerink Partners), Fan Yang (Venture Partner) and Greg Marshall (Investor) are shown as the contacts to pitch.
Across the known portfolio, 20 co-investors appear alongside Leerink Partners, including Brace Pharma Capital, Samsara BioCapital and Clarus Ventures.
Frequently asked questions
What is Leerink Partners?
Leerink Partners is a venture debt provider whose team is concentrated in Boston, Massachusetts, United States, with a known portfolio of 11 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What does Leerink Partners invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Drug Discovery, Genomics and Pharma. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.
What stage does Leerink Partners invest at?
The known deals of Leerink Partners include Growth and Series B rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.
Who should I pitch at Leerink Partners?
3 of the 4 people on file at Leerink Partners are listed as contacts for the firm. All 4 have their own profile page.
How do I contact Leerink Partners?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The 4 people attached to the firm have their own pages, each showing whether an address is on file for them.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal